Becton, Dickinson and Company is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Becton, Dickinson & Company, also known as BD, is a medical technology company that produces and sells medical devices and instrument systems. Its products cover interventional care, such as equipment needed to perform surgery; medical care, for example delivering medications and enhancing diabetes treatment; and life sciences solutions that equip researchers with lab tools and reagents.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Becton, Dickinson and Company creates positive Humankind Value on the whole. This outcome is largely driven by its contributions to Medical Devices ($117.7 B), Medical Services ($7.4 B), and Economic Value ($3.8 B). Positive value from Medical Devices and Medical Services contains our estimation of 2,400,000 additional years lived by people worldwide. This firm can increase its Humankind Value by addressing its impact on Biofuel Production (-$2.1 B) and Greenhouse Gases (-$1.4 B). Medical Devices, Economic Value, and Greenhouse Gases are attached to this company as a result of its direct business activities, while Medical Services and Biofuel Production are mostly or entirely a result of supply-chain relationships.